1. Home
  2. GSUN vs REVB Comparison

GSUN vs REVB Comparison

Compare GSUN & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSUN

Golden Sun Education Group Limited

HOLD

Current Price

$0.38

Market Cap

3.3M

Sector

Real Estate

ML Signal

HOLD

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$0.98

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSUN
REVB
Founded
1997
2020
Country
China
United States
Employees
N/A
9
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
GSUN
REVB
Price
$0.38
$0.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.0M
46.3K
Earning Date
02-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.47
52 Week High
$3.31
$2.93

Technical Indicators

Market Signals
Indicator
GSUN
REVB
Relative Strength Index (RSI) 56.27 42.76
Support Level $0.35 $0.96
Resistance Level $0.57 $1.21
Average True Range (ATR) 0.11 0.08
MACD 0.01 -0.01
Stochastic Oscillator 56.88 22.22

Price Performance

Historical Comparison
GSUN
REVB

About GSUN Golden Sun Education Group Limited

Golden Sun Technology Group Ltd operates two principal lines of business: tutorial services and e-commerce services. The company's e-commerce operations currently consist of data analytics-driven marketing and social media promotional services for small and medium-sized businesses on short video platforms based in China. The company's education centers offer two main programs, comprising of foreign language tutorial programs in less commonly taught languages, including, among other things, Spanish and Japanese, provided to individual students as well as to companies and other organizations; and Gaokao repeater tutorial programs, provided to individual students.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

Share on Social Networks: